Cargando…

Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes

PURPOSE: To explore guidelines on the use of MRI and PET/CT monitoring primary tumor response to neoadjuvant chemotherapy (NAC), taking breast cancer subtype into account. MATERIALS AND METHODS: In this prospective cohort study, 188 women were included with stages II and III breast cancer. MRI and (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitz, Alexander M. Th., Teixeira, Suzana C., Pengel, Kenneth E., Loo, Claudette E., Vogel, Wouter V., Wesseling, Jelle, Rutgers, Emiel J. Th., Valdés Olmos, Renato A., Sonke, Gabe S., Rodenhuis, Sjoerd, Vrancken Peeters, Marie Jeanne T. F. D., Gilhuijs, Kenneth G. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439668/ https://www.ncbi.nlm.nih.gov/pubmed/28531188 http://dx.doi.org/10.1371/journal.pone.0176782

Ejemplares similares

Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
por: van Ramshorst, Mette S., et al.
Publicado: (2017)

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer
por: Loo, Claudette E., et al.
Publicado: (2016)

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients
por: Straver, Marieke E., et al.
Publicado: (2010)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
por: Rigter, L S, et al.
Publicado: (2013)

Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
por: Ragusi, Max A. A., et al.
Publicado: (2020)

Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2- breast cancer
por: Ragusi, Max AA, et al.
Publicado: (2021)

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET
por: Koolen, B. B., et al.
Publicado: (2012)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival
por: van der Voort, Anna, et al.
Publicado: (2022)

Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients
por: Ragusi, Max A.A., et al.
Publicado: (2021)

Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?
por: Steenbruggen, Tessa G, et al.
Publicado: (2015)

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
por: Elshof, Lotte E., et al.
Publicado: (2018)

Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse
por: Borrelli, Pablo, et al.
Publicado: (2016)

Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol
por: van Loevezijn, Ariane A., et al.
Publicado: (2022)

History of sentinel node and validation of the technique
por: Tanis, Pieter J, et al.
Publicado: (2001)

Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study
por: van Loevezijn, Ariane A., et al.
Publicado: (2020)

A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples
por: Zwart, Wilbert, et al.
Publicado: (2013)

Agreement on Indication for Systemic Therapy between Biopsied Tissue and Surgical Excision Specimens in Breast Cancer Patients
por: Schmitz, Alexander M. Th., et al.
Publicado: (2014)

Survival and prognostic factors in oligometastatic breast cancer
por: van Ommen-Nijhof, Annemiek, et al.
Publicado: (2022)

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
por: Vliek, Sonja, et al.
Publicado: (2023)

ASO Author Reflections: The Pursuit of Eliminating Surgery after Neoadjuvant Systemic Therapy in Breast Cancer Patients
por: van Loevezijn, Ariane A., et al.
Publicado: (2020)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

Volumetric breast density estimation on MRI using explainable deep learning regression
por: van der Velden, Bas H. M., et al.
Publicado: (2020)

[(18)F]FDG-PET/CT in prone compared to supine position for optimal axillary staging and treatment in clinically node-positive breast cancer patients with neoadjuvant systemic therapy
por: van Loevezijn, Ariane A., et al.
Publicado: (2021)

Synchronous Breast Cancer: Phenotypic Similarities on MRI
por: Wang, Hui, et al.
Publicado: (2019)

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study
por: Elshof, Lotte E., et al.
Publicado: (2017)

Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2(+) breast cancer
por: Debets, Donna O., et al.
Publicado: (2023)

Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial
por: van Hemert, Annemiek K. E., et al.
Publicado: (2023)

Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI: protocol of the LIMA study – a multicentre prospective observational cohort study
por: Janssen, Liselore M, et al.
Publicado: (2022)

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients
por: Tanis, P J, et al.
Publicado: (2002)

Breast Cancer Subtype Specific Classifiers of Response to Neoadjuvant Chemotherapy Do Not Outperform Classifiers Trained on All Subtypes
por: de Ronde, Jorma J., et al.
Publicado: (2014)

Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with (18)F-FDG PET Radiomics Based Machine Learning Classification
por: Beukinga, Roelof J., et al.
Publicado: (2022)

Feasibility of preoperative (125)I seed-guided tumoural tracer injection using freehand SPECT for sentinel lymph node mapping in non-palpable breast cancer
por: Pouw, Bas, et al.
Publicado: (2014)

Harmonization of Quantitative Parenchymal Enhancement in T(1)‐Weighted Breast MRI
por: van der Velden, Bas H.M., et al.
Publicado: (2020)

Tumour-educated platelets for breast cancer detection: biological and technical insights
por: Liefaard, Marte C., et al.
Publicado: (2023)

Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights
por: Liefaard, Marte C., et al.
Publicado: (2023)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness
por: Lips, Esther H, et al.
Publicado: (2011)

Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?
por: Walstra, Coco J. E. F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7v9tkdvs1ji2idfaf63e3nj8n4